HCPLive Network

From the Literature: Alzheimer's Disease

Regional Differences in MRI Detection of Amyloid Plaques in AD Transgenic Mouse Brain
Journal: Neuroimage (August 20, 2010)
Authors: Wengenack T, Reyes D, Curran G, et al.
Purpose: To use “five-way anatomic spatial co-registration of MR images with three different histological techniques” to reveal “properties of amyloid plaques in AD transgenic mouse brain… that may explain their variable visibility in gradient- and spin-echo MR images,” as most MRI studies that attempt to detect plaques in AD transgenic mouse brains have “ployed techniques that exploit the paramagnetic effect of iron and have had mixed results.”
Results: In the MR imaging of human AD plaque, MRI methods might eventually be more successful if they rely less on iron magnetic susceptibility effect. This is especially believed by the authors because “human AD plaques more closely resemble the cortical and hippocampal plaques of AD transgenic mice than thalamic plaques.
Click here to access this thirdy-party resource.

Relative Capability of MR Imaging and FDG PET to Depict Changes Associated with Prodromal and Early Alzheimer Disease
Journal: Radiology (September 2010)
Authors: Karow D, McEvoy L, Fennema-Notestine C, et al.
Purpose: “To quantify the effect sizes of regional metabolic and morphometric measures in patients with preclinical and mild Alzheimer disease (AD) to aid in the identification of noninvasive biomarkers for the early detection of AD.”
Results: No evidence was found that flurodeoxyglucose positron emission tomography is more sensitive to preclinical and mild AD degeneration than is MR imaging. Thus, for early detection of AD, MR imaging findings might be more practical as clinical biomarkers.
Click here to access this thirdy-party resource.


Further Reading
Progress has been made toward widespread adoption of electronic health records, although there are still barriers to adoption of advanced use of EHRs, according to a report published by the Robert Wood Johnson Foundation.
The risks of marijuana are greatest for teen users, according to an analysis of current data from the National Institute on Drug Abuse (NIDA) published June 5, 2014 in The New England Journal of Medicine.
The International Antiviral Society–USA Panel has released its 2014 report, which provided clinical recommendations to stop HIV transmission.
Even though the active ingredient in marijuana can be associated with memory impairment, it may slow or halt Alzheimer’s disease.
Peripheral neuropathy was found in a third of HIV patients in a recent study of 58 men with a median age of 36 years.
Men who are socially well-integrated show more than a 2-fold reduced risk of suicide, according to a longitudinal study published in the Annals of Internal Medicine.
High sodium intake is associated with increased disease activity in multiple sclerosis, according to research published online Aug. 28 in the Journal of Neurology, Neurosurgery & Psychiatry.
More Reading